Dr. Laura Soucek is head of the Mouse Models of Cancer Therapies Group at the Vall d’Hebron Institute of Oncology (VHIO), an ICREA research professor and an associate professor at the Autonomous University of Barcelona. Ever since her undergraduate studies, she has focused her career on Myc inhibition. This project has been her personal dream and challenge for the past 20 years. Peptomyc won the Johnson & Johnson Start-up Slam Barcelona at BIO-Europe Spring for the best innovative project.
Paulo holds a PhD in Biomedical Engineering from the Eindhoven University of Technology, Netherlands, where he researched new technologies for cross-sectional brain imaging. In Barcelona, he became an associate researcher at the University of Barcelona, specializing in neuroimaging techniques. Then, he co-founded Mint Labs as CEO/CTO and has worked in this field over 10 years. He was named one of the Spanish Innovators under 35 by the MIT Technology Review in 2014.
Named an Innovator Under 35 of 2016 by the MIT Technology Review Spain, Javier Jiménez has taken a huge leap in his professional career thanks to New Born Solutions, which he co-founded and has been CEO of since 2015. He has a degree in telecommunications engineering from the UPC, an MBA from EAE and a PhD in biomedical engineering. He has worked professionally in computing, communication systems, the automotive sector and space communications but he is most passionate about biomedical imaging.
She has a degree in Veterinary studies, a master in Immunology and a PhD in pharmacology (including one year at the National Institute of Health in Bethesda). Mariona Serra began this new phase as an entrepreneur as a result of her post-doc at the Biomedical Research Institute of Girona. She complemented her training with a Program for Leadership Development at IESE and co-founded GoodGut in 2014, acting as CEO ever since. She is a member of the Social Council at the Autonomous University of Barcelona, where she presides over the University-Enterprise committee.
Founder and non-executive director of Inbiomotion and ICREA researcher at IRB Barcelona
Roger holds a degree in Biochemistry and Business and his research focus on cancer metastasis. He got his PhD in Biochemistry (UB) in 2002 and was a postdoc fellow in professor Massagué’s laboratory at the Memorial Sloan-Kettering Cancer Center. Since 2006, he is head of the "Growth control and cancer metastasis" laboratory at IRB Barcelona.
Ignasi Heras holds a degree in Business Administration and Management (ADE) from the UB and an MBA from EADA. He was deputy director of Biocontrol Technologies and head of Innovation, Marketing and Networking at the Barcelona Science Park. In 2012, he founded a consultancy firm and has been working at Transplant Biomedicals since 2014. He combines his professional career with education: he is a tutor and project consultant for the EADA master in management for the healthcare sector.